UCSF researchers report a new spatial repellent that provides up to one year of protection against malaria and other mosquito-borne diseases, marking the first WHO-endorsed vector control tool in over four decades.
In a concerted effort to combat the alarming issue of fatal drug deaths across the UK, the government has allocated £5 million to support 12 groundbreaking projects.
Poor adherence to drug therapies can lead to medication waste and poor patient outcomes. Tim Wooller shares some of the reasons behind poor adherence to medication and how connected drug delivery devices can help.
With a particular focus on South Korea, Open Access Government explores the changing perceptions around animal welfare and some of the policies introduced to support this.
Dr Nazneen Rahman, Founder and CEO of YewMaker and Sustainable Medicines Partnership (SMP) Director describes how tackling wasted medicines is crucial to achieving sustainable healthcare.
A groundbreaking study demonstrates the efficacy of administering a previously injection-only medication for osteoporosis through an innovative robotic pill.
AI and Anti-aging research: According to a study, AI algorithms (AI) has led to the discovery of three drugs that have the potential to delay the effects of aging.
Barney Reed, Senior Scientific Manager, Animals in Science Department at the RSPCA, stresses the need for ambitious strategies for phasing out the use of animals in science.
Blockchain wasn’t invented as a supply management tool; yet, today it is helping to solve some of the most complex problems existing in global supply chains.
Barney Reed, Senior Scientific Manager, Animals in Science Department at the RSPCA, stresses the need for ambitious strategies for phasing out the use of animals in science.
Monica Racoviță, Senior Researcher at The Health Policy Partnership, argues that opioid dependence is a pressing issue, yet treatment for it is still out of reach for many.
In a surprising turn of events, Prince Harry's public endorsement of the transformative power of psychedelic therapy has triggered a psychedelic resurgence in the UK.
